Vesedaganat: vizsgálatok itt: Hollandia
12 of 17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
- Where
- Amsterdam, Maastricht, Schiedam, 's-Gravenhage
- Életkor
- 18 év and over
- People
- 758 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Amsterdam, Maastricht, Zwolle
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 - 3. fázisTaking peopleStudy of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Amsterdam, Maastricht, Nijmegen, Schiedam, Utrecht, Zwolle
- Életkor
- 18 év and over
- People
- 720 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00 - 1. fázisNot yet taking people in HollandiaA Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 112 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07848295 - 3. fázisTaking peopleCARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
- Where
- Amsterdam, Eindhoven, Leiden, Maastricht, Rotterdam, Schiedam, Utrecht, Zwolle
- Életkor
- 18 év and over
- People
- 1373 worldwide
- Run by
- Institut Gustave Roussy
See details and how to join2023-503317-29-00 - 2. fázisTaking peopleCabozantinib Dose Skipping as an Alternative to Dose Reductions
- Where
- Leiden
- Életkor
- 18 év and over
- People
- 34
- Run by
- dr. Tom van der Hulle
See details and how to joinNCT07077161 · EU 2025-522962-58-00 - No phaseTaking peoplePromoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
- Where
- Arnhem, Nijmegen
- Életkor
- 18 év and over
- People
- 30
- Run by
- Radboud University Medical Center
See details and how to joinNCT07680556 - 3. fázisTaking peopleISEE-RCC study
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 20
- Run by
- Stichting Radboud universitair medisch centrum
See details and how to join2024-514181-39-00 - No phaseTaking peopleCBCT Guided Markerless SBRT for Renal Cell Cancer
- Where
- Rotterdam
- Életkor
- 18 év and over
- People
- 40
- Run by
- Erasmus Medical Center
See details and how to joinNCT07402109 - 3. fázisNot yet taking people in HollandiaCARE1 Pragmatic Clinical Trial
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 1250 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT06364631 - 4. fázisTaking peopleNivolumab dose optimization in patients with a complete, partial or stable response (NIVOPTIMIZE-trial)
- Where
- Rotterdam, Zwolle
- Életkor
- 18 év and over
- People
- 34
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to joinNCT06116461 · EU 2024-516718-39-00 - 2. fázisNot yet taking people in HollandiaNeoadjuvant AXITINIB plus AVELUMAB for patients with localized RCC and a moderate to high risk of recurrence
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 40
- Run by
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
See details and how to join2024-515825-27-00